Coeptis Therapeutics COEP Stock
Coeptis Therapeutics Price Chart
Coeptis Therapeutics COEP Financial and Trading Overview
| Coeptis Therapeutics stock price | 0.42 USD |
| Previous Close | 1.75 USD |
| Open | 1.73 USD |
| Bid | 0 USD x 900 |
| Ask | 0 USD x 800 |
| Day's Range | 1.67 - 1.85 USD |
| 52 Week Range | 1.03 - 21.42 USD |
| Volume | 227.9K USD |
| Avg. Volume | 465.42K USD |
| Market Cap | 38.56M USD |
| Beta (5Y Monthly) | -0.58957 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.83 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 5 USD |
COEP Valuation Measures
| Enterprise Value | 37.97M USD |
| Trailing P/E | N/A |
| Forward P/E | -2.5571427 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 29.344261 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -1.587 |
Trading Information
Coeptis Therapeutics Stock Price History
| Beta (5Y Monthly) | -0.58957 |
| 52-Week Change | -82.25% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 21.42 USD |
| 52 Week Low | 1.03 USD |
| 50-Day Moving Average | 1.56 USD |
| 200-Day Moving Average | 3.52 USD |
COEP Share Statistics
| Avg. Volume (3 month) | 465.42K USD |
| Avg. Daily Volume (10-Days) | 712.53K USD |
| Shares Outstanding | 21.54M |
| Float | 12.66M |
| Short Ratio | 2.34 |
| % Held by Insiders | 52.10% |
| % Held by Institutions | 19.49% |
| Shares Short | 272.01K |
| Short % of Float | 1.64% |
| Short % of Shares Outstanding | 1.26% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -245.54% |
| Return on Equity (ttm) | -1449.70% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -23928664 USD |
| Net Income Avi to Common (ttm) | -26262768 USD |
| Diluted EPS (ttm) | -1.4 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 2.11M USD |
| Total Cash Per Share (mrq) | 0.1 USD |
| Total Debt (mrq) | 1.7M USD |
| Total Debt/Equity (mrq) | 131.9 USD |
| Current Ratio (mrq) | 1.15 |
| Book Value Per Share (mrq) | 0.061 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -4598552 USD |
| Levered Free Cash Flow (ttm) | 2.64M USD |
Profile of Coeptis Therapeutics
| Country | United States |
| State | PA |
| City | Wexford |
| Address | 105 Bradford Road |
| ZIP | 15090 |
| Phone | 724 934 6467 |
| Website | https://coeptistx.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 4 |
Coeptis Therapeutics Holdings, Inc., a biopharmaceutical company, develops cell therapy platforms for patients with cancer. Its product portfolio consists of CD38-GEAR-NK, a cell therapy for the treatment of CD38-related cancers, including multiple myeloma, chronic lymphocytic leukemia, and acute myeloid leukemia; SNAP-CAR, a CAR T cell therapy platform co-administered with tagged, tumor-specific antibodies to potentially target different tumor types, including hematological malignancies and solid tumors; and CD38-Diagnostic, an in vitro screening tool to analyze if cancer patients might be appropriate candidates for anti-CD38 mAb therapy. The company has collaboration with Statera BioPharma to develop and commercialize STAT-201 for Crohn's disease; and Vici Health Sciences, LLC to co-develop and share ownership rights to CPT60621 for the treatment of Parkinson's Disease. Coeptis Therapeutics Holdings, Inc. is headquartered in Wexford, Pennsylvania.
Q&A For Coeptis Therapeutics Stock
What is a current COEP stock price?
Coeptis Therapeutics COEP stock price today per share is 0.42 USD.
How to purchase Coeptis Therapeutics stock?
You can buy COEP shares on the NasdaqCM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Coeptis Therapeutics?
The stock symbol or ticker of Coeptis Therapeutics is COEP.
Which industry does the Coeptis Therapeutics company belong to?
The Coeptis Therapeutics industry is Biotechnology.
How many shares does Coeptis Therapeutics have in circulation?
The max supply of Coeptis Therapeutics shares is 36.09M.
What is Coeptis Therapeutics Price to Earnings Ratio (PE Ratio)?
Coeptis Therapeutics PE Ratio is now.
What was Coeptis Therapeutics earnings per share over the trailing 12 months (TTM)?
Coeptis Therapeutics EPS is -0.83 USD over the trailing 12 months.
Which sector does the Coeptis Therapeutics company belong to?
The Coeptis Therapeutics sector is Healthcare.
Coeptis Therapeutics COEP included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16175.09 USD — |
-1.62
|
3.94B USD — | 16125.33 USD — | 16341.46 USD — | — - | 3.94B USD — |
| NASDAQ Global Market Composite NQGM | 2160.36 USD — |
-2.45
|
— — | 2147.48 USD — | 2200.33 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 958.68 USD — |
-2.07
|
— — | 954.08 USD — | 972.42 USD — | — - | — — |
- {{ link.label }} {{link}}